HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$4.71
Day range
$4.80 - $4.92
Year range
$3.00 - $4.98
Market cap
151.84M CAD
Avg Volume
13.27K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 12.62M | 1.20% |
Operating expense | 10.98M | -14.90% |
Net income | -4.44M | 27.35% |
Net profit margin | -35.14 | 28.21% |
Earnings per share | -0.14 | 26.32% |
EBITDA | 3.17M | 29.29% |
Effective tax rate | 0.52% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.73M | -8.79% |
Total assets | 153.95M | -22.15% |
Total liabilities | 87.15M | -19.82% |
Total equity | 66.80M | — |
Shares outstanding | 31.63M | — |
Price to book | 2.24 | — |
Return on assets | -3.49% | — |
Return on capital | -4.08% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.44M | 27.35% |
Cash from operations | 3.54M | 355.40% |
Cash from investing | -21.00K | -950.00% |
Cash from financing | -3.28M | -8.08% |
Net change in cash | 278.00K | 111.08% |
Free cash flow | 5.86M | 116.15% |
About
Founded
2014
Website
Employees
85
